ALPHATEC HOLDINGS, INC. (ATEC) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 237.97M USD | Liabilities, Current |
| Cash and equivalents | 118.66M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 110.13M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 194.89M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $237.97M | $118.66M | (m) | $110.13M | $194.89M | (m) |
| 2026-03-31 | (m) | $240.24M | $139.91M | (m) | $106.38M | $186.03M | (m) |
| 2025-12-31 | (m) | $219.18M | $160.81M | (m) | $97.30M | $169.44M | (m) |
| 2025-09-30 | (m) | $220.82M | $155.74M | (m) | $96.84M | $166.89M | (m) |
| 2025-06-30 | (m) | $154.18M | $157.06M | (m) | $95.92M | $169.76M | (m) |
| 2025-03-31 | (m) | $157.87M | $153.24M | (m) | $89.48M | $170.87M | (m) |
| 2024-12-31 | (m) | $153.03M | $138.84M | (m) | $82.99M | $175.26M | (m) |
| 2024-09-30 | (m) | $156.22M | $80.98M | (m) | $78.45M | $183.11M | (m) |
| 2024-06-30 | (m) | $169.45M | $99.83M | (m) | $83.98M | $172.31M | (m) |
| 2024-03-31 | (m) | $169.29M | $144.09M | (m) | $88.65M | $152.98M | (m) |
| 2023-12-31 | (m) | $157.57M | $220.97M | (m) | $72.61M | $136.84M | (m) |
| 2023-09-30 | (m) | $148.04M | $122.53M | (m) | $64.52M | $130.67M | (m) |
| 2023-06-30 | (m) | $138.75M | $101.02M | (m) | $59.93M | $119.96M | (m) |
| 2023-03-31 | (m) | $142.90M | $116.70M | (m) | $62.41M | $108.24M | (m) |
| 2022-12-31 | (m) | $138.87M | $84.70M | (m) | $60.06M | $101.52M | (m) |
| 2022-09-30 | (m) | $125.49M | $106.11M | (m) | $50.72M | $102.16M | (m) |
| 2022-06-30 | (m) | $121.31M | $107.47M | (m) | $43.93M | $102.80M | (m) |
| 2022-03-31 | (m) | $115.90M | $151.81M | (m) | $40.44M | $99.04M | (m) |
| 2021-12-31 | (m) | $101.09M | $187.25M | (m) | $41.89M | $91.70M | (m) |
| 2021-09-30 | (m) | $100.07M | (m) | (m) | $33.68M | $92.51M | (m) |
| 2021-06-30 | (m) | $107.56M | (m) | (m) | $33.74M | $86.72M | (m) |
| 2021-03-31 | (m) | $70.15M | (m) | (m) | $25.75M | $57.38M | (m) |
| 2020-12-31 | (m) | $58.31M | (m) | (m) | $23.53M | $46.00M | (m) |
| 2020-09-30 | (m) | $48.16M | (m) | (m) | $24.27M | $42.14M | (m) |
| 2020-06-30 | (m) | $42.80M | (m) | (m) | $19.79M | $41.47M | (m) |
| 2020-03-31 | (m) | $38.24M | (m) | (m) | $15.38M | $37.87M | (m) |
| 2019-12-31 | (m) | $36.39M | (m) | (m) | $16.15M | $34.85M | (m) |
| 2019-09-30 | (m) | $31.59M | (m) | (m) | $15.43M | $33.06M | (m) |
| 2019-06-30 | (m) | $31.01M | (m) | (m) | $13.64M | $32.60M | (m) |
| 2019-03-31 | (m) | $27.63M | (m) | (m) | $13.76M | $31.17M | (m) |
| 2018-12-31 | (m) | $30.61M | $29.05M | (m) | $15.10M | $28.77M | (m) |
| 2018-09-30 | (m) | $33.14M | (m) | (m) | $12.20M | $28.99M | (m) |
| 2018-06-30 | (m) | $35.03M | (m) | (m) | $11.40M | $28.18M | (m) |
| 2018-03-31 | (m) | $34.49M | (m) | (m) | $11.96M | $28.87M | (m) |
| 2017-12-31 | (m) | $29.74M | (m) | (m) | $14.82M | $27.29M | (m) |
| 2017-09-30 | (m) | $28.79M | (m) | (m) | $13.30M | $29.75M | (m) |
| 2017-06-30 | (m) | $29.57M | (m) | (m) | $13.13M | $29.81M | (m) |
| 2017-03-31 | (m) | $33.33M | (m) | (m) | $14.21M | $30.09M | (m) |
| 2016-12-31 | (m) | $40.13M | (m) | (m) | $18.51M | $30.09M | (m) |
| 2016-09-30 | (m) | $42.38M | (m) | (m) | $16.55M | $27.66M | (m) |
| 2016-06-30 | (m) | $125.23M | $9.32M | (m) | $36.52M | $44.14M | (m) |
| 2016-03-31 | (m) | $129.56M | $7.76M | (m) | $39.44M | $47.96M | (m) |
| 2015-12-31 | (m) | $125.40M | $11.23M | (m) | $38.32M | $44.91M | (m) |
| 2015-09-30 | (m) | $98.58M | $10.50M | (m) | $36.25M | $42.33M | (m) |
| 2015-06-30 | (m) | $53.31M | $8.90M | (m) | $38.86M | $41.24M | (m) |
| 2015-03-31 | (m) | $56.71M | $11.40M | (m) | $38.91M | $41.77M | (m) |
| 2014-12-31 | (m) | $63.60M | $19.73M | (m) | $40.44M | $41.75M | (m) |
| 2014-09-30 | (m) | $66.17M | $20.17M | (m) | $40.05M | $41.99M | (m) |
| 2014-06-30 | (m) | $69.79M | $18.98M | (m) | $44.66M | $42.45M | (m) |
| 2014-03-31 | (m) | $94.40M | $23.76M | (m) | $38.84M | $42.54M | (m) |
| 2013-12-31 | (m) | $79.72M | $21.34M | (m) | $41.40M | $41.94M | (m) |
| 2013-09-30 | (m) | $56.37M | $18.65M | (m) | $41.74M | $43.14M | (m) |
| 2013-06-30 | (m) | $49.81M | $12.95M | (m) | $41.03M | $50.61M | (m) |
| 2013-03-31 | (m) | $55.50M | $19.29M | (m) | $40.71M | $50.46M | (m) |
| 2012-12-31 | (m) | $56.79M | $22.24M | (m) | $41.01M | $49.85M | (m) |
| 2012-09-30 | (m) | $53.20M | $25.94M | (m) | $37.56M | $48.34M | (m) |
| 2012-06-30 | (m) | $50.16M | $22.02M | (m) | $38.80M | $47.41M | (m) |
| 2012-03-31 | (m) | $49.57M | $16.86M | (m) | $40.57M | $48.16M | (m) |
| 2011-12-31 | (m) | $57.14M | $20.67M | (m) | $41.71M | $45.92M | (m) |
| 2011-09-30 | (m) | $44.11M | $22.14M | (m) | $39.77M | $48.78M | (m) |
| 2011-06-30 | (m) | $42.53M | $21.76M | (m) | $41.71M | $47.97M | (m) |
| 2011-03-31 | (m) | (m) | $21.48M | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | $43.59M | $23.17M | (m) | $39.78M | $51.63M | (m) |
| 2010-09-30 | (m) | (m) | $28.85M | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | $38.41M | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | (m) | $10.09M | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | (m) | $18.32M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |